- Via Surgical received an investment from Catcher Technology, an Asian manufacturing company listed on the Taiwan Stock Exchange
- The amount of the deal not disclosed
- The new funding will also used to accelerate Via Surgical’s growth in the APAC region and will support development and production of its suture fixation system
- Via Surgical also provides the trademarked FasTouch™ deployable suture fixation system, which makes hernia repair surgeries less labor-intensive for surgeons and recovery less painful for patients
- The company has secured two U.S. Food and Drug Administration 510(k) clearances for the FasTouch™ Absorbable and FasTouch™ Permanent Fixation Systems
- Founded in 2012, the company also has 16 issued patents in the US and worldwide, and 17 additional provisional patents filed in the US
